The analysis of prognostic factors for glioblastoma multiforme

Jiabei Chen(Southern Medical University), Lei Yu(The People's Hospital of Guangxi Zhuang Autonomous Region), Songtao Qi(Nanfang Hospital), Yang-hui Ou(Nanfang Hospital), Ziyang Chen(Beijing Chemical Industry Research Institute (China)), Ming Chen(First Affiliated Hospital Zhejiang University), Siqiang Tang
Zhonghua shenjing waike zazhi
January 28, 2015
10.3760/cma.j.issn.1001-2346.2015.01.014
Cited by 1

Related Papers

<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
|Cancer Science|2011|296
Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC
|New England Journal of Medicine|2024|291
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
|Molecular Cancer|2014|228
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
|Brain|2019|186
Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms
|Oncology Letters|2014|169